Contract Pharma

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News

Sanofi, Moderna Enter COVID-19 Vaccine Fill/Finish Manufacturing Deal

Sanofi will provide fill/finish services for up to 200 million doses of Moderna’s COVID-19 vaccine in the U.S. beginning in September 2021.

Tim Wright, Editor, Contract Pharma 05.03.21

Biologics, Proteins, Vaccines | Breaking News | Industry News

Sanofi Invests in Cutting Edge Vax Production Site in Singapore

The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.

Kristin Brooks 04.12.21

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Sanofi Acquires Tidal Therapeutics

Gains novel mRNA-based technology with research capabilities in immuno-oncology and inflammatory diseases, with potential in other disease areas.

Kristin Brooks 04.12.21

Sanofi to Build New $700M Flu Vaccine Facility in Canada

Facility will be located in Toronto and will increase supply of influenza vaccines in Canada, the U.S. and Europe.

Tim Wright, Editor, Contract Pharma 04.05.21

APIs | Breaking News | Facilities | Industry News

Sanofi Unveils EUROAPI as Name of New European API Company

Appoints Karl Rotthier as its future Chief Executive Officer.

Contract Pharma Staff 01.15.21

Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News

Sanofi to Acquire Kiadis for $359M

Adds next-gen natural killer cell platform and pipeline of cell-based cancer immune-therapeutics and infectious disease therapies.

Contract Pharma Staff 11.03.20

Breaking News | Industry News

Sanofi to Acquire Principia Biopharma in $3.6B Deal

Principia's Bruton tyrosine kinase inhibitors add to Sanofi's efforts to accelerate a portfolio of next-gen treatments for autoimmune diseases.

Contract Pharma Staff 08.17.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Sanofi and GSK Selected for Operation Warp Speed

To supply U.S. government with 100 million doses of COVID-19 vaccine in $2.1 billion deal.

Contract Pharma Staff 08.03.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Sanofi and GSK Strike COVID-19 Vax Deal with UK Govt.

Will supply up to 60 million doses of the vaccine if approved, Phase 1/2 study expected to start in September.

Contract Pharma Staff 07.29.20

06 Sanofi

...

Tim Wright, Editor, Contract Pharma 07.15.20

Breaking News | Collaborations & Alliances | Drug Development

Kymera, Sanofi Enter Multi-program Strategic Alliance

To develop and commercialize first-in-class protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases.

Contract Pharma Staff 07.09.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News

Sanofi and Translate Bio Expand Vaccine Collaboration

To develop mRNA vaccines across all infectious disease areas in a deal potentially worth up to $1.9 billion.

Contract Pharma Staff 06.26.20

Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Sanofi Invests $679M in Two French Vaccine Sites

Will create a state-of-the-art vaccine production site and a new research center dedicated to vaccines

Contract Pharma Staff 06.16.20

Breaking News | Injectables | Packaging & Tracking

Schreiner MediPharm Supplies Booklet-Label for Sanofi Trial

Specialty Label for Needle Protection System comprises more than 30 pages, in more than 20 languages.

Contract Pharma Staff 05.07.20

Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings

Regeneron, Sanofi Release Preliminary Phase II Kevzara Results in COVID-19

Kevzara rapidly lowered C-reactive protein (CRP), a key marker of inflammation, meeting the primary endpoint.

Contract Pharma Staff 04.27.20

Breaking News | Industry News

FDA’s CTAP to Expedite COVID-19 Countermeasures

New program across public, academic and private sectors aims to expedite the development of life-saving treatments

Contract Pharma Staff 04.07.20

Breaking News | Industry News | Promotions & Moves

I-Mab Makes Executive Appointment

Names Gigi Feng as vice president and global head of corporate communications

03.24.20

Sanofi, Regeneron in COVID-19 Pact

Begin global Kevzara (sarilumab) clinical trial program in patients with severe COVID-19

03.16.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development

COVID-19 Clinical Trials

The vaccines in development for COVID-19, who's developing them, and where they stand in the development process

Online Exclusives Kristin Brooks, Contract Pharma 03.10.20

Chemistry

Greener by Design

How new approaches to green chemistry are driving sustainable processes.

Kenneth Ball, Commercial Operations Lead, Pfizer CentreOne 03.04.20

APIs | Breaking News | Industry News

Sanofi Creates New API Company in Europe

Will be world’s second largest API maker with €1 billion in sales by 2022

02.28.20

Breaking News | Industry News | Promotions & Moves

Vectura Expands Executive Leadership Team

Appoints Sharon Johnson as executive vice president for delivery management

02.10.20

Breaking News | Promotions & Moves

Eisai Expands Leadership Team

Adds two key appointments in the areas of Corporate Affairs and Market Access

02.03.20

Bio News | Breaking News | Facilities | Industry News

VIDEO: Boyd Releases “Global Biomanufacturing Costs” Report

John Boyd discusses details from his firm's new biomanufacturing site selection costs report.

01.24.20

Boyd Releases “Global Biomanufacturing Costs” Report

John Boyd discusses details from his firm's new biomanufacturing site selection costs report.

Videos

Breaking News | Collaborations & Alliances | Drug Development

Evotec Achieves Third Sanofi Milestone

Meets pre-agreed critical criteria within the beta cell replacement therapy program under diabetes research alliance

12.20.19

Breaking News | Industry News

Evotec, Sanofi Expand Services Agreement

Sanofi will transfer its liquid compounds to Evotec in Toulouse, combining central storage and sample delivery

12.19.19

Biologics, Proteins, Vaccines | Breaking News | Industry News

Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

U.S.-based, state-of-the-art facilities to be established for sustainable production of adjuvanted recombinant vaccine for use in the event of a pandemic.

Sanofi 12.13.19

Breaking News | Drug Development | Industry News

Sanofi Acquires Synthorx in $2.5B Deal

CA-based immuno-oncology company expands Sanofi's cancer and autoimmune pipeline

12.10.19

Breaking News | Drug Development | Promotions & Moves

Locana Appoints CEO

James Burns is an accomplished company builder and biopharmaceutical product developer

12.10.19

Breaking News | Collaborations & Alliances | Drug Development

Regeneron, Sanofi Amend Antibody Alliance

Sanofi to gain global rights to Kevzara and sole ex-U.S. rights to Praluent, Regeneron to gain sole U.S. rights to Praluent

12.10.19

Biologics, Proteins, Vaccines | Breaking News | Industry News

Sanofi Pasteur Awarded HHS Pandemic Flu Vax Contract

To increase domestic pandemic influenza vaccine production capabilities in Swiftwater, PA

12.09.19

Logistics | Serialization | Supply Chain

Sanofi Genzyme on Trends in Pharma Supply Chains

Jim Calarese of Sanofi Genzyme discusses how merging two companies can prove even more difficult when their supply chains are highly dissimilar

Videos

Biologics, Proteins, Vaccines | Facilities

Sanofi Ushers in Next-Gen Biotech Manufacturing

Opens its first digitally-enabled continuous manufacturing facility.

Slideshows10.18.19

Biologics, Proteins, Vaccines | Breaking News | Industry News | Information Technology

Sanofi Ushers in Next-Gen Biotech Manufacturing

Opens its first digitally-enabled continuous manufacturing facility

10.15.19

Cytotoxics and High Potency Manufacturing

Highly Potent Expansions

CDMOs see HPAPI demand rising

S. Harachand, Contributing Editor 09.16.19

Promotions & Moves

CANbridge Appoints SVP, Rare Disease Commercial Operations

Marcelo Cheresky brings nearly 20 years' business leadership experience in the biotechnology industry

07.30.19

cGMP Manufacture | Industry News

Opiant Pharmaceuticals, Sanofi to Manufacture Acute Cannabinoid Overdose Treatment

Opiant’s drinabant, selective cannabinoid receptor antagonist, could be first approved treatment for ACO

07.24.19

Top 25 Pharma and Biopharma Companies

(Based on 2018 Pharma/Biopharma Sales, in $U.S. Millions)

Tim Wright & Kristin Brooks 07.18.19

Top 25 Pharma and Biopharma Companies

...

07.15.19

05 Sanofi

...

07.15.19

The Top Companies Report

Combined sales for 2018 topped the $600 billion mark

Tim Wright, Editor 07.15.19

cGMP Manufacture | Industry News | Scale-up/Technology Transfer

Catalent Expands Global Spray Drying Ops

Agreement with Sanofi Active Ingredient Solutions provides access to spray drying manufacturing services at Sanofi’s Haverhill, UK facility

07.09.19

Industry News | R&D

Sanofi Restructures R&D Group

To eliminate 466 jobs in France and Germany as part of a reorganization to focus on its immuno-oncology pipeline and gene therapies

06.21.19

Drug Development | Drug Discovery | Industry News | Laboratory Testing

Sanofi and Google to Develop Innovation Lab

Virtual healthcare Innovation Lab aims to radically transform how future medicines and health services are delivered

06.18.19

Collaborations & Alliances | Drug Development

Voyager Therapeutics, Sanofi Genzyme Restructure Gene Therapy Alliance

Voyager gains worldwide rights to VY-HTT01 Huntington’s disease program and ex-U.S. rights to VY-FXN01 Friedreich’s ataxia program for $10 million upfront

06.17.19

Industry News